Interleukin-15 gene polymorphism in children with celiac disease: a single-center experience
Single Center
Abdominal distension
DOI:
10.1007/s00431-025-06108-6
Publication Date:
2025-04-23T06:19:04Z
AUTHORS (6)
ABSTRACT
Abstract The purpose of this study is to evaluate the demographics, clinical presentation, laboratory findings, and gastrointestinal endoscopic findings in children with CD assess their relationship interleukin-15 (IL-15) single-nucleotide polymorphism (SNP) (rs2857261) serum IL-15 levels. This case–control prospective cohort included 54 newly diagnosed pediatric patients attending Gastroenterology Clinic at Alexandria University Children’s Hospital 44 age- sex-matched healthy controls. Demographics, data, tests, Marsh classification, SNP genotypes were analyzed. Follow-up after 9 months on a gluten-free diet (GFD) was conducted. mean age controls 8.62 ± 4.4 8.07 4.7 years, respectively, no significant difference ( p = 0.55). Male representation 48.1% 47.7% 0.97). most common presenting symptoms abdominal distension (61.11%) failure thrive (59.26%). Laboratory showed that anti-tissue transglutaminase immunoglobulin A 103 168 U/ml, anti-endomysium positive 51.85% patients. Histopathological assessment revealed 3C as finding (37%), while 37% without biopsy. analysis significantly higher prevalence A/A genotype compared < 0.0001). A/G G/G protective against CD, odds ratios 0.088 0.079, respectively. No associations observed between clinical, laboratory, or histological variables. After 6 GFD, did not influence symptom resolution > 0.05). Conclusions : Serum levels are elevated associated increased susceptibility appear protective. These highlight potential biomarker therapeutic target CD. Further large-scale studies warranted validate these explore applications. What Known: • Celiac disease an immune-mediated enteropathy linked HLA-DQ2/DQ8 alleles, playing key role its pathogenesis. Variability genetic polymorphisms has been suggested but remains underexplored populations. New: identifies risk factor for Elevated target.
SUPPLEMENTAL MATERIAL
Coming soon ....
REFERENCES (46)
CITATIONS (0)
EXTERNAL LINKS
PlumX Metrics
RECOMMENDATIONS
FAIR ASSESSMENT
Coming soon ....
JUPYTER LAB
Coming soon ....